CNC:NYE-Centene Corp (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 58.19

Change

0.00 (0.00)%

Market Cap

USD 28.86B

Volume

4.32M

Analyst Target

USD 85.36
Analyst Rating

Sell

ducovest Verdict
Created with Highstock 5.0.6

Slightly Bearish

About

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
CNC VTI
  • VTI
Relative Returns (From:    To: 2025-03-16 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

N/A

USD 446.97B
ELV Elevance Health Inc

N/A

USD 93.09B
MOH Molina Healthcare Inc

N/A

USD 17.11B
OSCR Oscar Health Inc

N/A

USD 3.66B
NEUE NeueHealth Inc

N/A

USD 0.06B
CI Cigna Corp

N/A

N/A
CVS CVS Health Corp

N/A

N/A
HUM Humana Inc

N/A

N/A

ETFs Containing CNC

XSDX:SW Xtrackers ShortDAX Daily .. 4.53 % 0.00 %

N/A

USD 0.19B
MVPA Advisor Managed Portfolio.. 4.45 % 0.00 %

N/A

USD 0.07B
AVDR 2.70 % 0.00 %

N/A

N/A
DXSD:F 2.30 % 0.00 %

N/A

N/A
DXSD:XETRA 2.30 % 0.00 %

N/A

N/A
FXH First Trust Health Care A.. 2.15 % 0.63 %

N/A

USD 1.01B
XZEW:XETRA Xtrackers S&P 500 Equal W.. 0.39 % 0.00 %

N/A

N/A
XDED:XETRA Xtrackers S&P 500 Equal W.. 0.22 % 0.00 %

N/A

N/A
SP2D:XETRA Invesco S&P 500 Equal Wei.. 0.22 % 0.00 %

N/A

USD 0.21B
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

N/A

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

N/A

N/A
JNKS:LSE SSgA SPDR ETFs Europe I p.. 0.00 % 0.00 %

N/A

USD 0.21B
SYBK:F SSgA SPDR ETFs Europe I p.. 0.00 % 0.00 %

N/A

USD 0.14B
SYBK:XETRA SPDR Barclays 0-5 Year US.. 0.00 % 0.00 %

N/A

N/A
XDEW:XETRA Xtrackers S&P 500 Equal W.. 0.00 % 0.00 %

N/A

N/A
GBLO 0.00 % 0.00 %

N/A

N/A
NVQ 0.00 % 0.00 %

N/A

N/A
FHH-F:CA First Trust AlphaDEX U.S... 0.00 % 0.00 %

N/A

CAD 0.01B
FSBD Fidelity Sustainable Core.. 0.00 % 0.00 %

N/A

USD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.95% 22% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.95% 22% F 33% F
Trailing 12 Months  
Capital Gain -22.90% 44% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.90% 44% F 11% F
Trailing 5 Years  
Capital Gain 0.34% 33% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.34% 33% F 13% F
Average Annual (5 Year Horizon)  
Capital Gain 0.96% 56% F 37% F
Dividend Return 0.96% 44% F 26% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 26.54% 33% F 40% F
Risk Adjusted Return 3.60% 33% F 23% F
Market Capitalization 28.86B 67% D+ 93% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.